Related Experiment Videos
Cytogenetic instability in young patients with multiple primary cancers
Ulrike Keller1, Gerhard Grabenbauer, Alma Kuechler
1Department of Radiation Oncology, Friedrich-Alexander-University Erlangen-Nuremberg, Universitätsstrasse 27, D-91054 Erlangen, Germany.
Cancer Genetics and Cytogenetics
|January 29, 2005
Summary
Young patients with multiple cancers and a family history of cancer often show cytogenetic instability. This instability, indicated by chromosomal aberrations, suggests a higher risk in these individuals.
Area of Science:
- Genetics
- Oncology
- Cytogenetics
Background:
- Multiple primary cancers in individuals under 45, especially with a family cancer history, are rare.
- Cytogenetic instability is a hallmark of cancer development and progression.
Purpose of the Study:
- To investigate the presence and extent of cytogenetic instability in young patients (<45 years) with multiple independent cancers and a family history of cancer.
- To compare chromosomal aberration levels in this patient group with healthy controls, radiosensitive patients, and single-tumor patients.
Main Methods:
- Analysis of peripheral blood lymphocytes from 50 individuals (19 multiple cancer patients, 15 single tumor patients, 11 healthy controls, 5 radiosensitive controls).
- In vitro irradiation of lymphocytes (0.7 Gy, 2.0 Gy) followed by 3-color fluorescence in situ hybridization (FISH) on chromosomes 1, 2, and 4.
- Quantification of chromosomal aberrations, including breaks per metaphase (B/M) and complex chromosomal rearrangements per metaphase (CCR/M).
Main Results:
- A subset of 5 patients exhibited very high levels of chromosomal aberrations (B/M and CCR/M) compared to all control groups.
- An additional 10 patients showed moderately elevated chromosomal aberrations.
- Four patients displayed aberration levels similar to healthy controls.
Conclusions:
- A significant proportion of young patients with multiple tumors and a family cancer history exhibit underlying cytogenetic instability.
- This finding suggests that cytogenetic instability may be a contributing factor or a marker for hereditary cancer predisposition in this demographic.
- Further research is warranted to explore the clinical implications and potential diagnostic utility of assessing cytogenetic instability in these high-risk individuals.